AtriCure, Inc. (ATRC)

NASDAQ: ATRC · USD

$61.3

-0.23 (-0.4%)· Recorded snapshot

Market cap	3.1B
Revenue (ttm)	569.6M
Net income (ttm)	10.6M
EPS (ttm)	$0.21
Shares out	50.9M
P/E (trailing)	290.7x
P/E (forward)	259.4x
Volume	530,445
Beta	1.25

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 569.6M
Net income (ttm): 10.6M
EPS (ttm): $0.21
P/E (trailing): 290.7x
P/E (forward): 259.4x
Market cap: 3.1B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Держать

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E259.4

P25 n/aP50 n/aP75 n/a

Trailing P/E290.7

P25 n/aP50 n/aP75 n/a

ROE2.2

P25 n/aP50 n/aP75 n/a

ROIC2.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ATRC indicators

Market & fundamental data

Available fields

252

Groups with data

Currency

USD

Showing 252 of 252 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001323885
Company name	AtriCure, Inc.
Country	United States
Country code	US
CUSIP number	04963C209
Earnings date	2026-11-03
Earnings time	amc
Employees	1,350
Employees change	50
Employees growth	3.85%
Enterprise value	$3B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2000
In index	RUSSELL2000
Industry	Medical Instruments & Supplies
IPO date	2005-08-05
Is primary listing	Yes
Is SPAC	No
ISIN number	US04963C2098
Last 10-K release date	2026-02-19
Last earnings date	2026-07-23
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$3.1B
Market cap category	Mid-Cap
Next earnings date	2026-11-03
Options	Yes
Price	$61.29
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	ATRC
U.S. state	Ohio
Website	https://www.atricure.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	266.46x
Earnings yield	0.34%
EV/Earnings	290.25x
EV/EBIT	237.6x
EV/EBITDA	90.76x
EV/FCF	57.66x
EV/Sales	5.38x
FCF / EV yield	1.73%
FCF yield	1.68%
Forward EV/Sales	4.77x
Forward P/E	259.39x
Forward P/S	4.91x
Graham number	6.94011
Graham upside	-88.82%
Industry forward P/E	22.69x
Industry P/E	75.18x
P/(FCF - SBC) ratio	540.08x
P/(OCF - SBC) ratio	178.63x
P/B ratio	6.06x
P/E ratio	290.68x
P/FCF ratio	59.42x
P/OCF ratio	48.6x
P/S ratio	5.54x
Price / tangible book value	13.24x
Price/EBITDA ratio	93.53x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	2.26%
EBITDA margin	5.92%
Effective tax rate	12.75%
FCF margin	9.32%
Gross margin	76.3%
Operating margin	2.26%
Pretax margin	2.12%
Profit margin	1.85%
Profit per employee	$7,816
Profitable quarters	3
Revenue per employee	$421,942
ROA	1.25%
ROA (5Y)	-3.49%
ROCE	2.17%
ROE	2.15%
ROE (5Y)	-3.46%
ROIC	2.67%
ROIC (5Y)	-8.87%
SBC / revenue	8.3%
Tax / revenue	0.27%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (QoQ)	8,074.39%
EPS growth quarters	1
EPS growth years	1
FCF growth	110.05%
FCF growth (Q)	-2.79%
Gross profit growth	16.35%
Gross profit growth (Q)	16.9%
Gross profit growth 3Y	16.69%
Gross profit growth 5Y	19.1%
Net income growth (QoQ)	8,191.67%
Net income growth quarters	6
Net income growth years	1
OCF growth	78.25%
OCF growth (Q)	2.66%
Revenue growth	13.94%
Revenue growth (Q)	12.83%
Revenue growth (QoQ)	8.75%
Revenue growth 10Y	14.86%
Revenue growth 3Y	15.92%
Revenue growth 5Y	18.56%
Revenue growth quarters	22
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-11.8M
Depreciation and amortization	$20.9M
EBIT	$12.9M
EBITDA	$33.7M
EPS	$0.21
FCF per share	$1.04
Financing cash flow	$-1.9M
Free cash flow	$53.1M
Free cash flow minus SBC	$5.8M
Gross profit	$434.6M
Income taxes	$1.5M
Investing cash flow	$-12.8M
Net borrowing	$4.1M
Net cash flow	$50M
Net income	$10.6M
Operating cash flow minus SBC	$17.7M
Operating income	$12.9M
Revenue	$569.6M
Stock-based compensation	$47.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	6.77
Book value per share	$10.15
Debt / EBITDA	2.07
Debt / equity	0.14
Debt / FCF	1.4
Goodwill	$234.8M
Interest coverage	2.29
Long-term assets	$331.1M
Long-term liabilities	$78.3M
Net cash (debt)	$93.6M
Net cash / market cap	2.96%
Net cash growth	130.77%
Net debt / EBITDA	-2.77
Net debt / equity	-0.18
Net debt / FCF	-1.76
Piotroski F-Score	8
Property, plant and equipment	$48.5M
Shareholders' equity	$516.4M
Tangible book value	$238.4M
Tangible book value per share	$4.69
Total assets	$676.6M
Total cash	$167.8M
Total debt	$74.2M
Total liabilities	$160.2M
WACC	11.02%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.89
Current assets	$345.5M
Current liabilities	$81.9M
Current ratio	4.22
Inventory turnover	1.68
Net working capital	$99M
Quick ratio	3.02
Working capital	$263.6M
Working capital turnover	2.44

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-2.5%
Dividend yield	0%
Shareholder yield	-2.5%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	304.54%
10Y return CAGR	15%
10Y total return	304.54%
150-day SMA	$39.24
15Y price change	410.12%
15Y return CAGR	11.48%
15Y total return	410.12%
1D price change	-0.37%
1M price change	5.29%
1M total return	5.29%
1W price change	6.59%
1W total return	6.59%
1Y price change	68.55%
1Y return CAGR	68.61%
1Y total return	68.55%
20-day SMA	$56.96
200-day SMA	$37.84
20Y price change	678.1%
20Y return CAGR	10.8%
20Y total return	678.1%
3M price change	64.49%
3M total return	64.49%
3Y price change	84.37%
3Y return CAGR	22.62%
3Y total return	84.37%
50-day SMA	$55.01
50-day SMA vs 200-day SMA	50over200
52-week high	$63.00
52-week high date	2026-10-28
52-week low	$25.36
52-week low date	2026-06-02
5Y price change	-18.63%
5Y return CAGR	-4.04%
5Y total return	-18.63%
6M price change	111.67%
6M total return	111.67%
All-time high	$89.18
All-time high date	2021-11-05
All-time low	$1.00
All-time low date	2009-04-24
Average true range (ATR)	$2.13
Average volume	787.3K
Beta (1Y)	0.34
Beta (2Y)	0.64
Beta (5Y)	1.25
Change from 52-week high	-2.72%
Change from 52-week low	141.66%
Change from all-time high	-31.07%
Change from all-time low	6,047%
Change from open	-0.35%
Day's gap	-0.02%
Dollar volume	$32.5M
High price	$62.88
Low price	$61.15
Monthly RSI	71.74
Open price	$61.50
Position in 52-week range	7.8%
Premarket change	0.49%
Premarket close	$61.51
Premarket price	$61.81
Previous close	$61.51
Price vs 150-day SMA	56.66%
Price vs 20-day SMA	7.91%
Price vs 200-day SMA	62.47%
Price vs 50-day SMA	11.74%
Relative volume	0.67
RSI	66.45
Sharpe ratio	1.27
Sharpe ratio (3Y)	0.54
Sharpe ratio (5Y)	0.09
Sortino ratio	2.06
Sortino ratio (3Y)	0.93
Sortino ratio (5Y)	0.25
Volume	530.4K
Weekly RSI	80.86
YTD price change	55.38%
YTD total return	55.38%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	48.8M
Float percentage	95.99%
Shares change (QoQ)	-0.36%
Shares change (YoY)	2.5%
Shares held by insiders	4.01%
Shares held by institutions	112.12%
Shares outstanding	50.9M
Short % of float	9.87%
Short % of shares	9.47%
Short ratio	3.2 days

Deeper analysis on ATRC

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ATRC report

Is a complete ATRC research report available?

No complete published report is available for AtriCure, Inc. (ATRC) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

AtriCure, Inc. (ATRC)

Price

Financial snapshot

Fair-value bridge

Latest news · ATRC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ATRC indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ATRC

Frequently asked questions